Syncor Corp. to Buy Iodine 123 Business

Syncor International Corp., a Chatsworth operator of nuclear pharmacies, said that it has signed a letter of intent with Golden Pharmaceuticals Inc. to buy the company’s Iodine 123 business.

Iodine 123 is used to diagnose thyroid problems.

Previously, Golden was supplying Iodine 123 to Syncor’s network of 130 nuclear pharmacy service centers.